Attached files
| file | filename |
|---|---|
| 10-K - 10-K - AERIE PHARMACEUTICALS INC | aeri-1231201410xk.htm |
| EX-32.1 - EXHIBIT 32.1 - AERIE PHARMACEUTICALS INC | aeri12312014ex-321.htm |
| EX-32.2 - EXHIBIT 32.2 - AERIE PHARMACEUTICALS INC | aeri12312014ex-322.htm |
| EX-31.2 - EXHIBIT 31.2 - AERIE PHARMACEUTICALS INC | aeri12312014ex-312.htm |
| EX-31.1 - EXHIBIT 31.1 - AERIE PHARMACEUTICALS INC | aeri12312014ex-311.htm |
| EXCEL - IDEA: XBRL DOCUMENT - AERIE PHARMACEUTICALS INC | Financial_Report.xls |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (No. 333-199821) and Form S-8 (No. 333-192030) of Aerie Pharmaceuticals, Inc. of our report dated February 27, 2015 relating to the financial statements, which appears in this Form 10-K.
/s/ PricewaterhouseCoopers LLP
Florham Park, NJ
February 27, 2015